GlucoModicum today published a peer-reviewed article highlighting key insights into its non-invasive glucose biosensor technology. Helsinki, Finland-based GlucoModicum published its findings in Biosensors and Bioelectronics. The company said it highlights key features of the development of ultra-sensitive electrochemical glucose biosensors. Its work reflects efforts in engineering and system-level design, forming the basis of the company’s product […]
Diabetes
MannKind earns expanded FDA labeling for inhaled insulin
MannKind (Nasdaq:MNKD) announced today that it received FDA approval for an update to the prescribing information for Afrezza inhaled insulin. Afrezza (insulin human) inhalation powder is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion […]
Abbott reportedly looks to expand CGM manufacturing plant in Ireland
Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland. According to the report, Abbott hopes to extend its existing industrial building and alter its vehicle entrance and parking lot at the IDA Business and Technology Park in Kilkenny. The report states that the proposed extension would result in […]
New Dexcom CEO Jake Leach talks 2026 roadmap, next-gen tech
After more than 100 days in the corner office at CGM maker Dexcom (NSDQ:DXCM), CEO Jake Leach is excited for the company’s future. In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession process. He took over a few months early as outgoing […]
Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump
Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump. The partnership aims to bring DBLG2, Diabeloop’s newest automated insulin delivery (AID) algorithm, to twiist. DBLG2 picked up FDA clearance last month. Sequel becomes the latest pump maker to adopt the algorithm, with ViCentra planning to […]
Dexcom stock rises on Street-beating preliminary Q4 sales
Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus forecast. For the quarter ended Dec. 31, 2025, the company expects total revenue of $1.26 billion. That marks a 13% increase over the same period a year ago and lands just ahead of expectations on Wall Street. Dexcom expects to report […]
Medtronic wins FDA clearance for MiniMed Go app for InPen smart insulin pen
Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI). MiniMed Go, a smart MDI system, integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within the app to deliver real-time, personalized insights and actionable guidance. Medtronic and […]
CamDiab earns CE mark for fully closed-loop insulin delivery algorithm
CamDiab announced that it received European approval for its fully closed-loop automated insulin delivery algorithm. The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal insulin. Cambridge, UK-based CamDiab said it marks the world’s first commercially available automated insulin delivery algorithm that enables people with type 1 […]
Analysts downgrade Beta Bionics on new patient starts miss
Analysts downgraded Beta Bionics (Nasdaq:BBNX) to “Neutral” following preliminary fourth-quarter results that fell shy of expectations. Shares of BBNX fell 35% to $20.86 apiece in early-morning trading today. Beta Bionics, which has completed its first full year as a public company following its IPO last year, pre-announced fourth-quarter revenues of $32 million. That came in […]
Senseonics launches Eversense 365 CGM with Sequel twiist pump
Senseonics (NYSE:SENS) announced today that it began the launch of its Eversense 365 sensor with the Sequel Med Tech twiist pump. The companies said today that the first commercial patients have now received their paired continuous glucose monitor (CGM) and automated insulin delivery (AID) system. They announced their intent to integrate technologies in April 2025. […]
